# Ventricular Pacing Site Selection (V-PASS)

> **NCT00292383** · PHASE4 · UNKNOWN · sponsor: **Medtronic BRC** · enrollment: 100 (estimated)

## Conditions studied

- Atrioventricular Block

## Interventions

- **PROCEDURE:** Leads to be implanted according randomization on specified sites. Vitatron pacemakers to be implanted: T60 DR, T70 DR, T20 SR, C60 DR

## Key facts

- **NCT ID:** NCT00292383
- **Lead sponsor:** Medtronic BRC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292383, "Ventricular Pacing Site Selection (V-PASS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00292383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*